Question 1

What is Kiniksa Pharmaceuticals International, plc's deferred tax assets and other non-current assets?

Accepted Answer

Kiniksa Pharmaceuticals International, plc (KNSA) reported deferred tax assets and other non-current assets of $10.83M in Q2 2026.

Question 2

How has Kiniksa Pharmaceuticals International, plc's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Kiniksa Pharmaceuticals International, plc's deferred tax assets and other non-current assets increased by 32.2% year-over-year, from $8.2M to $10.83M.

Question 3

What is the long-term trend for Kiniksa Pharmaceuticals International, plc's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's deferred tax assets and other non-current assets has grown at a 15.1% compound annual growth rate (CAGR), from $5.59M to $11.31M.

Line item	June 30, 2026	December 31, 2025
Total current assets	668,633	527,177
Property and equipment, net	2,575	1,943
Operating lease right-of-use assets	8,353	9,807
Other long-term assets	10,834	11,307
Intangible asset, net	14,750	15,250
Deferred tax assets	190,965	198,149
Total assets	$896,110	$763,633
Liabilities and Shareholders’ Equity

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Kiniksa Pharmaceuticals International, plc's deferred tax assets and other non-current assets.

Kiniksa Pharmaceuticals International, plc KNSA Deferred Tax Assets and Other Non-Current Assets